These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3334572)

  • 1. Effects of cephalosporins and carumonam on blood coagulation.
    Havel M; Graninger W; Korninger H; Kurz R; Müller M; Horcher E
    Chemioterapia; 1987 Jun; 6(2 Suppl):334-5. PubMed ID: 3334572
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cefotaxime, ceftriaxone and latamoxef on blood coagulation in patients on parenteral nutrition.
    Graninger W; Kurz RW; Havel MP; Horcher E; Müller MM
    Chemotherapy; 1987; 33(6):452-8. PubMed ID: 3123153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective randomized study: cefuroxime and netilmicin versus ceftriaxone as prophylaxis in vascular surgery].
    Muckenhuber P; Salem G
    Wien Med Wochenschr Suppl; 1985; 87():27-8. PubMed ID: 3885582
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of perioperative prophylaxis with ceftriaxone and cefotaxime in vaginal hysterectomy with and without anterior and/or posterior colporrhaphy.
    Harms E; Schumacher C
    Chemioterapia; 1987 Jun; 6(2 Suppl):622-3. PubMed ID: 3334650
    [No Abstract]   [Full Text] [Related]  

  • 5. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In-vitro activity of cefotaxime].
    Knothe H
    Wien Klin Wochenschr Suppl; 1983; 142():4-7. PubMed ID: 6316671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose prophylaxis of ceftriaxone versus standard dosage of cefotaxime in the prophylaxis of bacterial complications in orthopedic surgery.
    Karachalios T; Lyritis G; Hatzopoulos E; Sapkas G
    Chemioterapia; 1987 Jun; 6(2 Suppl):573-5. PubMed ID: 3334628
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
    Muller A; Lopez-Lozano JM; Bertrand X; Talon D
    J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Listeria to cefotaxime and moxalactam.
    Rotstein C; Farrar WE
    Can Med Assoc J; 1982 Aug; 127(4):277. PubMed ID: 6284331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
    García-Contreras F; Del-Angel-García G; Ramírez Cuenca A; Malváez-Valdes M; Vega Yáñez A; Amato D
    Rev Invest Clin; 2000; 52(4):418-26. PubMed ID: 11061104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The newest cephalosporins: how to use them?
    Ehrenkranz NJ; Hoffman TA
    J Fla Med Assoc; 1982 Oct; 69(10):863-4. PubMed ID: 6292322
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of ceftriaxone on the blood coagulation parameters of intensive care patients].
    Schäfer JH; Arntz R; Emde C; Heitz J; Kittler R
    Wien Med Wochenschr Suppl; 1985; 87():16-21. PubMed ID: 3856971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of beta-lactam antibiotics on blood coagulation during maxillofacial surgery].
    Aderhold L
    Dtsch Z Mund Kiefer Gesichtschir; 1986; 10(4):307-11. PubMed ID: 3482029
    [No Abstract]   [Full Text] [Related]  

  • 20. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.